Skeletal disorders associated with the growth hormone–insulin-like growth factor 1 axis
Top Cited Papers
- 14 March 2022
- journal article
- review article
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 18 (6) , 353-365
Abstract
Growth hormone (GH) and insulin-like growth factor 1 (IGF1) are important regulators of bone remodelling and metabolism and have an essential role in the achievement and maintenance of bone mass throughout life. Evidence from animal models and human diseases shows that both GH deficiency (GHD) and excess are associated with changes in bone remodelling and cause profound alterations in bone microstructure. The consequence is an increased risk of fractures in individuals with GHD or acromegaly, a condition of GH excess. In addition, functional perturbations of the GH–IGF1 axis, encountered in individuals with anorexia nervosa and during ageing, result in skeletal fragility and osteoporosis. The effect of interventions used to treat GHD and acromegaly on the skeleton is variable and dependent on the duration of the disease, the pre-existing skeletal state, coexistent hormone alterations (such as those occurring in hypogonadism) and length of therapy. This variability could also reflect the irreversibility of the skeletal structural defect occurring during alterations of the GH–IGF1 axis. Moreover, the effects of the treatment of GHD and acromegaly on locally produced IGF1 and IGF binding proteins are uncertain and in need of further study. This Review highlights the pathophysiological, clinical and therapeutic aspects of skeletal fragility associated with perturbations in the GH–IGF1 axis.Keywords
This publication has 164 references indexed in Scilit:
- Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γProceedings of the National Academy of Sciences, 2012
- Insulin-like growth factor-binding protein-2 is required for osteoclast differentiationJournal of Bone and Mineral Research, 2011
- Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosaJournal of Bone and Mineral Research, 2011
- The Insulin-like Growth Factor-1 Binding Protein Acid-labile Subunit Alters Mesenchymal Stromal Cell FateJournal of Biological Chemistry, 2010
- Hormone predictors of abnormal bone microarchitecture in women with anorexia nervosaBone, 2010
- Regulation of gene expression in osteoblastsBioFactors, 2010
- Myostatin inhibits IGF-I-induced myotube hypertrophy through AktAmerican Journal of Physiology-Cell Physiology, 2009
- Effects of rhIGF-1 administration on surrogate markers of bone turnover in adolescents with anorexia nervosaBone, 2009
- Serum complexes of insulin‐like growth factor‐1 modulate skeletal integrity and carbohydrate metabolismThe FASEB Journal, 2008
- Inhibition of Growth Hormone Signaling by the Fasting-Induced Hormone FGF21Cell Metabolism, 2008